🔥Hot Off the Press | New study highlights #DLAT’s key role in chemotherapy resistance via acetylation & metabolic rewiring. #DMp39, a novel decoy #peptide, shows promise as a targeted #mitochondrial therapy—optimization could pave the way for clinical use.
#CancerTherapy